Matthew Krebs, The University of Manchester
Matt is also an Honorary Consultant in Medical Oncology at The Christie Dr Krebs completed his Medical undergraduate training at the University of Leicester in 2001 and general medical training in Manchester in 2005. He specialty trained in Medical Oncology at The Christie NHS Foundation Trust, was awarded a PhD in circulating biomarkers with application to drug development in 2011 and completed training as an academic clinical lecturer with post-doctoral experience in single cell molecular profiling.
Dr Krebs was appointed to his current position as Clinical Senior Lecturer in Experimental Cancer Medicine in 2014. He undertakes early-phase clinical trials with interests in drug development for lung cancer and precision medicine. His translational research focuses on the clinical application of circulating tumour DNA to guide personalised treatment selection and to monitor treatment response and resistance. He has been Principal or Chief Investigator on >40 and co-investigator on >75 early phase clinical trials across a broad range of novel therapies. He is lead for Precision Medicine within the Experimental Cancer Medicine Team, Chief Investigator of the TARGET Precision Medicine program, Chair of the Manchester Molecular Tumour Board and co-theme lead for Clinical Trials within the CRUK Manchester-UCL Lung Cancer Centre of Excellence.